<DOC>
	<DOCNO>NCT01138514</DOCNO>
	<brief_summary>The purpose study compare efficacy safety profile Perrigo Israel Pharmaceuticals , Ltd. Clindamycin 1 % /Benzoyl Peroxide 5 % Topical Gel BenzaclinÂ® Topical Gel ( Clindamycin- Benzoyl Peroxide Gel ) .</brief_summary>
	<brief_title>Clinical Study Between Two Clindamycin 1 % /Benzoyl Peroxide 5 % Topical Gels</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Clindamycin palmitate</mesh_term>
	<mesh_term>Clindamycin phosphate</mesh_term>
	<mesh_term>Benzoyl Peroxide</mesh_term>
	<criteria>Healthy men woman , 12 65 year age Willing participate sign provide write consent Moderate severe acne Pregnant lactate woman History unresponsiveness hypersensitivity clindamycin , benzoyl peroxide lincomycin Use systemic , topical facial product may interfere study Participation clinical study 30 day prior study entry Prolonged exposure sunlight excessive exposure UV light Chronic use NSAIDS</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>